FdaApplication

ANDA 218497

Back to search

Identifiers

Properties

PropertyValue
applicant_nameNOVITIUM PHARMA LLC
application_typeANDA
approval_date2024-06-12

Products (2)

ProductActive ingredientStrengthDosage form
NAPROXENNAPROXEN375MGTABLET, DELAYED RELEASE;ORAL
NAPROXENNAPROXEN500MGTABLET, DELAYED RELEASE;ORAL

2 products